China Meheco Co Ltd (600056) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China Meheco Co Ltd (600056) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.60 Million ≈ $34.18 Million USD) by net assets (CN¥14.29 Billion ≈ $2.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See China Meheco Co Ltd (600056) balance sheet quality index to measure how much of total assets are equity-financed.
China Meheco Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how China Meheco Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600056 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
China Meheco Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Meheco Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Spartan Resources Ltd
AU:SPR
|
-0.015x |
|
Atea ASA
OL:ATEA
|
-0.248x |
|
Far Eastern International Bank
TW:2845
|
-0.049x |
|
Jiangsu Eazytec Co Ltd
SHG:688258
|
0.025x |
|
Intralot S.A. Integrated Lottery Systems and Services
AT:INLOT
|
0.306x |
|
Alamo Group Inc
NYSE:ALG
|
0.058x |
|
ATS CORP
TO:ATS
|
0.064x |
|
Berli Jucker PCL
BK:BJC
|
0.035x |
Annual Cash Flow Conversion Efficiency for China Meheco Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of China Meheco Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see China Meheco Co Ltd (600056) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥14.36 Billion ≈ $2.10 Billion |
CN¥1.43 Billion ≈ $208.65 Million |
0.099x | +39.32% |
| 2024-12-31 | CN¥14.11 Billion ≈ $2.06 Billion |
CN¥1.01 Billion ≈ $147.13 Million |
0.071x | +15.19% |
| 2023-12-31 | CN¥13.89 Billion ≈ $2.03 Billion |
CN¥859.08 Million ≈ $125.71 Million |
0.062x | -50.49% |
| 2022-12-31 | CN¥13.17 Billion ≈ $1.93 Billion |
CN¥1.65 Billion ≈ $240.84 Million |
0.125x | +953.06% |
| 2021-12-31 | CN¥12.51 Billion ≈ $1.83 Billion |
CN¥148.42 Million ≈ $21.72 Million |
0.012x | -90.70% |
| 2020-12-31 | CN¥12.22 Billion ≈ $1.79 Billion |
CN¥1.56 Billion ≈ $228.18 Million |
0.128x | +2710.68% |
| 2019-12-31 | CN¥11.01 Billion ≈ $1.61 Billion |
CN¥-53.82 Million ≈ $-7.88 Million |
-0.005x | -19320.94% |
| 2018-12-31 | CN¥10.14 Billion ≈ $1.48 Billion |
CN¥257.81K ≈ $37.73K |
0.000x | -99.96% |
| 2017-12-31 | CN¥8.88 Billion ≈ $1.30 Billion |
CN¥509.18 Million ≈ $74.51 Million |
0.057x | -56.14% |
| 2016-12-31 | CN¥7.68 Billion ≈ $1.12 Billion |
CN¥1.00 Billion ≈ $146.92 Million |
0.131x | -22.80% |
| 2015-12-31 | CN¥6.04 Billion ≈ $883.69 Million |
CN¥1.02 Billion ≈ $149.59 Million |
0.169x | -6.73% |
| 2014-12-31 | CN¥5.48 Billion ≈ $802.14 Million |
CN¥994.84 Million ≈ $145.58 Million |
0.181x | +5036.82% |
| 2013-12-31 | CN¥3.87 Billion ≈ $566.76 Million |
CN¥-14.24 Million ≈ $-2.08 Million |
-0.004x | -100.88% |
| 2012-12-31 | CN¥2.30 Billion ≈ $337.08 Million |
CN¥961.25 Million ≈ $140.66 Million |
0.417x | +1339.80% |
| 2011-12-31 | CN¥1.91 Billion ≈ $279.87 Million |
CN¥55.43 Million ≈ $8.11 Million |
0.029x | +112.57% |
| 2010-12-31 | CN¥1.61 Billion ≈ $235.47 Million |
CN¥-371.14 Million ≈ $-54.31 Million |
-0.231x | -138.50% |
| 2009-12-31 | CN¥1.62 Billion ≈ $236.70 Million |
CN¥968.97 Million ≈ $141.79 Million |
0.599x | +842.73% |
| 2008-12-31 | CN¥1.18 Billion ≈ $172.37 Million |
CN¥-95.01 Million ≈ $-13.90 Million |
-0.081x | -351.45% |
| 2007-12-31 | CN¥1.54 Billion ≈ $225.72 Million |
CN¥-27.56 Million ≈ $-4.03 Million |
-0.018x | -111.26% |
| 2006-12-31 | CN¥716.57 Million ≈ $104.86 Million |
CN¥113.73 Million ≈ $16.64 Million |
0.159x | +377.29% |
| 2005-12-31 | CN¥766.70 Million ≈ $112.19 Million |
CN¥-43.88 Million ≈ $-6.42 Million |
-0.057x | -175.36% |
| 2004-12-31 | CN¥661.58 Million ≈ $96.81 Million |
CN¥50.24 Million ≈ $7.35 Million |
0.076x | +176.13% |
| 2003-12-31 | CN¥626.26 Million ≈ $91.64 Million |
CN¥-62.48 Million ≈ $-9.14 Million |
-0.100x | +55.27% |
| 2002-12-31 | CN¥583.37 Million ≈ $85.37 Million |
CN¥-130.10 Million ≈ $-19.04 Million |
-0.223x | -141.16% |
| 2001-12-31 | CN¥550.11 Million ≈ $80.50 Million |
CN¥298.04 Million ≈ $43.61 Million |
0.542x | +285.16% |
| 2000-12-31 | CN¥512.65 Million ≈ $75.02 Million |
CN¥-150.01 Million ≈ $-21.95 Million |
-0.293x | -132.04% |
| 1999-12-31 | CN¥380.35 Million ≈ $55.66 Million |
CN¥347.36 Million ≈ $50.83 Million |
0.913x | +464.02% |
| 1998-12-31 | CN¥382.07 Million ≈ $55.91 Million |
CN¥-95.85 Million ≈ $-14.03 Million |
-0.251x | -- |
About China Meheco Co Ltd
China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and en… Read more